VRTX
NASDAQStockVertex Pharmaceuticals Incorporated
$479.41-13.10 (-2.66%)
52-Week Range
$366.54
$513.76
Key Stats
Market Cap
121.8B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.32
Volume
940.1K
Avg Volume
1.4M
Performance
1M
+3.66%
3M
+4.92%
6M
+21.60%
YTD
+5.75%
1Y
-4.93%
3Y
+61.94%
5Y
+117.68%
Price Chart
ETF Exposure
VRTX is held by 370 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| DMRL | DeltaShares S&P 500 Managed Risk ETF | 0.14% |
| DFSU | Dimensional - US Sustainability Core 1 ETF | 0.14% |
| HIPR | Direxion High Growth ETF | 0.14% |
| ACWI | iShares MSCI ACWI ETF | 0.14% |
| UPRO | ProShares - UltraPro S&P500 | 0.14% |
| PRF | Invesco RAFI US 1000 ETF | 0.13% |
| GLOV | Goldman Sachs ActiveBeta World Low Vol Plus Equity ETF | 0.13% |
| GSWO | Goldman Sachs ActiveBeta World Equity ETF | 0.13% |
| KOMP | State Street SPDR S&P Kensho New Economies Composite ETF | 0.13% |
| NZAC | State Street SPDR MSCI ACWI Climate Paris Aligned ETF | 0.13% |
| PHDG | Invesco S&P 500 Downside Hedged ETF | 0.13% |
| JHML | John Hancock Investments - Multifactor Large Cap ETF | 0.12% |
| MXDU | Nationwide Maximum Diversification U.S. Core Equity ETF | 0.12% |
| CRBN | iShares Low Carbon Optimized MSCI ACWI ETF | 0.11% |
| VT | Vanguard Total World Stock ETF | 0.11% |
| GSLC | Goldman Sachs ActiveBeta U.S. Large Cap Equity ETF | 0.11% |
| SPUT | Innovator Equity Premium Income – Daily PutWrite ETF | 0.11% |
| FNDX | Schwab Fundamental U.S. Large Company Index ETF | 0.10% |
| AIEQ | Amplify AI Powered Equity ETF | 0.10% |
| SPUU | Direxion Daily S&P 500 Bull 2X ETF | 0.10% |
| DFVX | Dimensional - US Large Cap Vector ETF | 0.10% |
| VLU | State Street SPDR S&P 1500 Value Tilt ETF | 0.10% |
| EQAL | Invesco Russell 1000 Equal Weight ETF | 0.10% |
| DFLV | Dimensional - US Large Cap Value ETF | 0.10% |
| FNDB | Schwab Fundamental U.S. Broad Market Index ETF | 0.09% |
| MMTM | State Street SPDR S&P 1500 Momentum Tilt ETF | 0.09% |
| DFAC | Dimensional - US Core Equity 2 ETF | 0.09% |
| IUS | Invesco RAFI Strategic US ETF | 0.09% |
| LSLT | Pacer Salt Low truBeta US Market ETF | 0.09% |
| SLT | Pacer Salt High truBeta US Market ETF | 0.09% |
| TRPL | Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF | 0.09% |
| VETS | Pacer Military Times Best Employers ETF | 0.09% |
| VIRS | Pacer BioThreat Strategy ETF | 0.09% |
| HCMT | Direxion HCM Tactical Enhanced US ETF | 0.08% |
| QARP | Xtrackers Russell 1000 US Quality at a Reasonable Price ETF | 0.08% |
| GEW | Cambria Global EW ETF | 0.08% |
| VFVA | Vanguard U.S. Value Factor ETF | 0.07% |
| RVRS | Arrow Reverse Cap 500 ETF | 0.07% |
| RWL | Invesco S&P 500 Revenue ETF | 0.07% |
| EAOA | iShares ESG Aware 80/20 Aggressive Allocation ETF | 0.07% |
| DCOR | Dimensional - US Core Equity 1 ETF | 0.07% |
| CPI | IQ Real Return ETF | 0.07% |
| SPGM | State Street SPDR Portfolio MSCI Global Stock Market ETF | 0.06% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.06% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.06% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.06% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.06% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.05% |
| EAOR | iShares ESG Aware 60/40 Balanced Allocation ETF | 0.05% |
| AOA | iShares Core 80/20 Aggressive Allocation ETF | 0.05% |
About VRTX ETF Exposure
Vertex Pharmaceuticals Incorporated (VRTX) is held by 370 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 121.8B, VRTX is a widely held institutional stock. The stock currently trades at $479.41. Investors can gain exposure to VRTX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold VRTX, sorted by portfolio weight.